Clinical trial
Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine
NCT00310336 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00310336 |
|---|---|
| Title | Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine |
| Official title | Chronic Hepatitis C: Treatment of (Peg)Interferon Alpha - Ribavirin Non-Responders With Pegylated Interferon alpha2b, Ribavirin, AdoMet and Betaine |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | S-adenosyl-L-methionine, betaine, pegylated interferon alpha2b, ribavirin |
| Enrollment | 30 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Apr 3, 2006 |
| Last update posted | Oct 28, 2010 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: